Comparative efficacy, safety, and acceptability of single-agent poly (ADP-ribose) polymerase (PARP) inhibitors in BRCA-mutated HER2-negative metastatic or advanced breast cancer: a network meta-analysis
Keyword(s):
2020 ◽
Vol 18
(3.5)
◽
pp. CLO20-066
Keyword(s):
Keyword(s):
2010 ◽
Vol 137
(6)
◽
pp. 1005-1013
◽
Keyword(s):
2018 ◽
Vol Volume 10
◽
pp. 5869-5880
◽
Keyword(s):
2013 ◽
Vol 143
(1)
◽
pp. 125-133
◽
2019 ◽
Vol Volume 11
◽
pp. 3349-3350
◽
Keyword(s):
2018 ◽
Vol 10
◽
pp. 175883591877692
◽